1. Home
  2. MTRX vs RCKT Comparison

MTRX vs RCKT Comparison

Compare MTRX & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matrix Service Company

MTRX

Matrix Service Company

HOLD

Current Price

$9.85

Market Cap

275.6M

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

SELL

Current Price

$2.57

Market Cap

239.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MTRX
RCKT
Founded
1984
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.6M
239.3M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
MTRX
RCKT
Price
$9.85
$2.57
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
★ $8.58
AVG Volume (30 Days)
474.9K
★ 2.0M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 91.51
26.37
EPS
N/A
★ 0.66
Revenue
★ $873,632,000.00
N/A
Revenue This Year
$6.70
N/A
Revenue Next Year
$5.71
$915.60
P/E Ratio
★ N/A
$3.75
Revenue Growth
★ 13.56
N/A
52 Week Low
$9.38
$2.17
52 Week High
$15.97
$5.45

Technical Indicators

Market Signals
Indicator
MTRX
RCKT
Relative Strength Index (RSI) 46.02 49.65
Support Level $9.67 $2.17
Resistance Level $10.84 $2.78
Average True Range (ATR) 0.34 0.17
MACD -0.03 0.06
Stochastic Oscillator 42.46 75.48

Price Performance

Historical Comparison
MTRX
RCKT

About MTRX Matrix Service Company

Matrix Service Co provides engineering, fabrication, construction, and maintenance services supporting critical energy infrastructure and industrial markets. Its reportable segments are Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities, with Storage and Terminal Solutions generating the maximum revenue. This segment provides integrated EPC, repair, maintenance, and fabrication services for bulk liquid, cryogenic, and refrigerated storage and terminal facilities supporting traditional and emerging energy markets, including LNG, NGLs, petroleum products, chemicals, hydrogen, and ammonia, and manufactures specialty tank products. The majority of revenue is generated from the United States.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: